Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. aTyr Pharma's Pre-Tax Income for the
three
months ended in Dec. 2023 was $-14.76 Mil. aTyr Pharma's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil. Therefore, aTyr Pharma's pretax margin for the quarter that ended in Dec. 2023 was %.
The historical rank and industry rank for aTyr Pharma's Pretax Margin % or its related term are showing as below:
LIFE'
s Pretax Margin % Range Over the Past 10 Years
Min: -14276.77 Med: -3033.81 Max: -155.24
Current: -14276.77
LIFE's Pretax Margin % is ranked worse than 92.71% of 1029
companies
in the Biotechnology industry
Industry Median: -177.81
vs LIFE: -14276.77
aTyr Pharma Pretax Margin % Historical Data
The historical data trend for aTyr Pharma's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of aTyr Pharma's Pretax Margin %
For the Biotechnology subindustry, aTyr Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aTyr Pharma's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, aTyr Pharma's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where aTyr Pharma's Pretax Margin % falls into.
aTyr Pharma Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
aTyr Pharma's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
aTyr Pharma Pretax Margin % Related Terms
Thank you for viewing the detailed overview of aTyr Pharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LIFE has been successfully added to your 